arcusbio.com is a domain that was created on 2015-04-29,making it 9 years ago. It has several subdomains, such as investors.arcusbio.com , among others.
Description:Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer...
Discover arcusbio.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 77.807 KB |
Page Load Time: 0.504646 Seconds |
Website IP Address: 141.193.213.20 |
Cancer Epigenetics | A journal of the Cancer Epigenetics Society | Cancer Epigenetics ce.b2sg.org |
BTF Cancer Center - Transforming Cancer Treatment in Nepal cancer.binayfoundation.org |
Pediatric Cancer Research Foundation | PCRF | Childhood Cancer Charity cure.pcrf-kids.org |
Insight – Cancer Information You Can Trust | Dana-Farber Cancer Institute blog.dana-farber.org |
Community Cancer Services | Mount Sinai Cancer Collaborative cancercollaborative.mountsinai.org |
Arcus Biosciences - Investors & Media investors.arcusbio.com |
MD Anderson Cancer Center: Cancer Treatment & Cancer Research Hospital | MD Anderson Cancer Center www3.mdanderson.org |
ARCUS archive.arcus.org |
Arcus Andura Systems laser.axiomamerica.com |
Nail fungus cure - Pythium oligandrum cures all skin fungi pythium-oligandrum.owndoc.com |
National Foundation for Cancer Research (NFCR): We Make Cures Possible action.nfcr.org |
Arcus Biosciences | Pursuit of Cures for Cancer https://arcusbio.com/ |
Careers https://arcusbio.com/careers/ |
Arcus Biosciences Clinical Trials | Cancer Clinical Trials https://trials.arcusbio.com/ |
Editorials https://arcusbio.com/editorials/ |
Sitemap https://arcusbio.com/sitemap/ |
Sitemap https://trials.arcusbio.com/sitemap |
Privacy Policy https://arcusbio.com/privacy-policy/ |
Sign Up For Updates | Keep Up To Date With Arcus https://arcusbio.com/sign-up/ |
About Us https://arcusbio.com/about-us/ |
Current Openings | Careers https://arcusbio.com/current-opportunities/ |
A arcusbio.com. 3600 IN A 141.193.213.21 |
MX arcusbio.com. 3600 IN MX 10 mxa-003e7301.gslb.pphosted.com. |
NS arcusbio.com. 21600 IN NS ns-1049.awsdns-03.org. |
TXT arcusbio.com. 3600 IN TXT 5ij0d0jmoi67r41n51ic6b8gr1 |
SOA arcusbio.com. 900 IN SOA ns-1049.awsdns-03.org. awsdns-hostmaster.amazon.com. 1 7200 900 1209600 86400 |
Date: Sat, 11 May 2024 12:29:38 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
x-powered-by: WP Engine |
Link: https://arcusbio.com/wp-json/; rel="https://api.w.org/", https://arcusbio.com/wp-json/wp/v2/pages/66; rel="alternate"; type="application/json", https://arcusbio.com/; rel=shortlink |
X-Cacheable: SHORT |
Cache-Control: max-age=10000, s-maxage=10000, must-revalidate |
X-Cache: HIT: 3 |
X-Cache-Group: normal |
CF-Cache-Status: DYNAMIC |
Server: cloudflare |
CF-RAY: 88222cfaec2069b5-LAX |
alt-svc: h3=":443"; ma=86400 |
charset="utf-8"/ |
content="width=device-width, initial-scale=1, shrink-to-fit=no viewport-fit=cover" name="viewport"/ |
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots" |
content="Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer therapies." name="description" |
content="en_US" property="og:locale"/ |
content="website" property="og:type"/ |
content="Arcus Biosciences | Pursuit of Cures for Cancer" property="og:title"/ |
content="Arcus is a biopharmaceutical company aiming to bring together scientists, physicians & advisors to focus on developing best-in-class cancer therapies." property="og:description"/ |
content="https://arcusbio.com/" property="og:url"/ |
content="Arcus Biosciences" property="og:site_name"/ |
content="2024-02-22T14:32:37+00:00" property="article:modified_time"/ |
content="summary_large_image" name="twitter:card"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
Arcus BiosciencesAbout Arcus Leadership Board of Directors Scientific Advisory Board Contact Us Our Science Pipeline Clinical Candidates Overview Anti-TIGIT domvanalimab Adenosine Axis etrumadenant quemliclustat Anti-PD-1 (zimberelimab) HIF-2⍺ Inhibitor (casdatifan) Anti-CD39 (AB598) AXL Inhibitor (AB801) Clinical Trials Clinical Trials Investigator Sponsored Expanded Access Program Publications Editorials Careers InvestorsMedia Overview Press Releases EventsPresentations Events Calendar Presentations Stock Information Analyst Coverage Stock Information SEC Filings Corporate Governance Governance Documents Management Team Board of Directors Committee Composition Contact Investor Relations Contact Investor Relations FAQs Email Alerts Follow Us X LinkedIn Sign Up for UpdatesAbout Arcus Leadership Board of Directors Scientific Advisory Board Contact Us Our Science Pipeline Clinical Candidates Overview Anti-TIGIT domvanalimab Adenosine Axis etrumadenant quemliclustat Anti-PD-1 (zimberelimab) HIF-2⍺ Inhibitor (casdatifan) Anti-CD39 (AB598) AXL Inhibitor (AB801) Clinical Trials Clinical Trials Investigator Sponsored Expanded Access Program Publications Editorials Careers InvestorsMedia Overview Press Releases EventsPresentations Events Calendar Presentations Stock Information Analyst Coverage Stock Information SEC Filings Corporate Governance Governance Documents Management Team Board of Directors Committee Composition Contact Investor Relations Contact Investor Relations FAQs Email Alerts Follow Us X LinkedIn Sign Up for Updates COMBINING TO CURE ® People and science are a beautiful combination. Arcus is at the forefront of designing combination therapies, with best-in-class potential, in our relentless pursuit of cures for cancer. Featured Gilead and Arcus Announce Amended Collaboration and Equity Investment Read More We are combiningWe are combining DISCOVERY CAPABILITIES Producing differentiated small molecules and antibodies designed to optimize combinability ACCELERATED DEVELOPMENT Guided by specific biologic mechanisms of cancer, to advance combination therapies from Phase 1 studies through commercialization PARTNERSHIP WITH THE CANCER COMMUNITY To facilitate participation in our global clinical trials and bring new medicines to patients faster Joining forces to defeat cancer. This is COMBINING TO CURE Explore More Read our latest press releases and announcements Browse Join forces with us on our mission to defeat cancer Connect Arcus clinical trials are currently enrolling Sign UpArcus Biosciences is a registered trademark of Arcus Biosciences, Inc. © 2024 Arcus Biosciences, Inc. All rights reserved. 3928 Point Eden Way, Hayward, CA 94545Our Science Editorials Careers InvestorsMedia Contact Terms of Use Sitemap Privacy Policy Washington Health Data Privacy Policy Cookie Policy Do Not Sell/Share My Personal...
Domain Name: ARCUSBIO.COM Registry Domain ID: 1924593052_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-02-08T03:25:43Z Creation Date: 2015-04-29T23:06:35Z Registry Expiry Date: 2031-04-29T23:06:35Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1049.AWSDNS-03.ORG Name Server: NS-1985.AWSDNS-56.CO.UK Name Server: NS-32.AWSDNS-04.COM Name Server: NS-949.AWSDNS-54.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T13:09:08Z <<<